Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma

Shiv K. Gupta, Sani H. Kizilbash, Brett L. Carlson, Ann C. Mladek, Felix Boakye-Agyeman, Katrina K. Bakken, Jenny L. Pokorny, Mark A. Schroeder, Paul A. Decker, Ling Cen, Jeanette E. Eckel-Passow, Gobinda Sarkar, Karla V. Ballman, Joel M. Reid, Robert B. Jenkins, Roeland G. Verhaak, Erik P. Sulman, Gaspar J. Kitange, Jann N. Sarkaria

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences